Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAS1R3 | Q7RTX0 | 5/20 | 0.60 |
| ▸ | TAS1R1 | Q7RTX1 | 5/20 | 0.60 |
| ▸ | TAS1R2 | Q8TE23 | 3/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | DRD4 | P21917 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1999696 | 0.82 | TRPV1 (0.44) | TAS1R3TAS1R1TAS1R2DRD4ACHE | |
| SCHEMBL1565272 | 0.79 | DRD4 (0.64) | TAS1R3TAS1R1TAS1R2CA1CA2 | |
| SCHEMBL1564910 | 0.78 | TAS1R3 (0.65) | TAS1R3TAS1R1TAS1R2CA1CA2 | |
| SCHEMBL3210493 | 0.78 | ALDH1A1 (0.62) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL3209924 | 0.77 | PDE10A (0.41) | TAS1R3TAS1R1TAS1R2ACHE | |
| SCHEMBL4475562 | 0.77 | DRD4 (0.62) | TAS1R3TAS1R1TAS1R2CA1CA2 | |
| SCHEMBL3219949 | 0.77 | ALDH1A1 (0.53) | TAS1R3TAS1R1TAS1R2 | |
| SCHEMBL5923920 | 0.76 | TAS1R3 (0.87) | TAS1R3TAS1R1TAS1R2CA1CA2 | |
| SCHEMBL4475437 | 0.76 | DRD4 (0.61) | TAS1R3TAS1R1TAS1R2CA1CA2 | |
| SCHEMBL3730549 | 0.75 | TAS1R3 (0.80) | TAS1R3TAS1R1TAS1R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100048699-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2010-02-25 | — | — | US | claimed |
| US-20100048699-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2010-02-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048699-A1 | CHEMICAL COMPOUNDS | ACHE, TYR, SGMS1 | TAS1R3 816/4885TAS1R1 527/4885TAS1R2 1005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.